NCT07281781
Treating Anemia in Myelofibrosis With Repurposed Drugs (Nelfinavir) That Restore Iron Delivery to the Bone Marrow
StatusRecruiting
PhasePhase 1/2
Primary completion (estimated)
At risk: Primary completion moved at least 11 months later.
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 4 versions: 3 with changes below, 1 re-verified with no change. See every version on ClinicalTrials.gov ↗
- Notable Primary completion pushed from Jun 2026 to Jun 2027
- Eligibility criteria expanded, about 22 words
- Minor Secondary endpoints revised (2)v3
- Study First Submitted
- Notable: the plan changed
- Minor: routine updates
Endpoints
Primary
Change in Hepcidin Levels
Timeframe: 30 days
Secondary (2)
Change in Hemoglobin Levels
Change From Baseline in Serum Fibrosis Biomarker Concentrations
Arms and interventions
NelfinavirExperimental
Given Orally
Drugs: Nelfinavir
Sites
1 site in 1 country
- Chao Family Comprehensive Cancer Center, University of California, IrvineOrange, California, United States